comparemela.com

Latest Breaking News On - Duccio manetti - Page 1 : comparemela.com

KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®

Since 2018 Kedrion has had exclusive distribution rights in the US for KEDRAB®, a Human Rabies Immune Globulin developed in partnership with Kamada Ltd.New agreement becomes effective in January.

Czech republicUnited statesUnited kingdomCastelvecchio pascoliKedrion biopharmaDuccio manettiBio products laboratoryKamada ltdHuman rabies immune globulinDamir londonRabies immune globulinNeurological disordersSecondary immunodeficienciesHemolytic diseaseChief communication officer

FDA Grants Import Discretion of Bracco s Iodinated Contrast Medium Iomeron® (iomeprol injection) to Address Supply Shortages

MILAN, July 27, 2022 /PRNewswire/ Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A., one of the world s leading companies in .

United statesDuccio manettiJeff flemingKimberly gerweckPatheon italiaMicaela colamasiGlobal communicationsDrug administrationBracco diagnostics incPrnewswire bracco diagnostics incBracco groupMarketing communicationsNuclear medicineBracco imaging press officeDiagnostics incChief executive officer

GADOPICLENOL: ANOTHER MILESTONE ACHIEVED

Priority Review of the Gadopiclenol NDA granted by the U.S. Food and Drug Administration MILAN, March 31, 2022 /PRNewswire/ Bracco is very exci.

Duccio manettiMicaela colamasiFulvio renoldi braccoGlobal communicationsDrug administrationBracco groupNuclear medicineEuropean unionNo regulatory authorityUs agencyBracco imaging press officePriority reviewNew drug applicationMarketing authorization applicationBracco imagingCentral nervous system

Bracco Imaging S p A : GADOPICLENOL: ANOTHER MILESTONE ACHIEVED

Priority Review of the Gadopiclenol NDA granted by the U.S. Food and Drug Administration" MILAN, March 31, 2022 /PRNewswire/ Bracco is very excited about the Priority Review granted

Duccio manettiKostenloser wertpapierhandelPrnewswire braccoMicaela colamasiFulvio renoldi braccoGlobal communicationsDrug administrationBracco groupNuclear medicineEuropean unionNo regulatory authorityUs agencyBracco imaging press officePriority reviewNew drug applicationMarketing authorization application

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications

Philochem and Bracco Imaging Announce a Collaboration on the Development of a Small Molecule for Diagnostic or Medical Imaging Applications - read this article along with other careers information, tips and advice on BioSpace

Duccio manettiGiuliano falivaMary jane elliottDavide salviDario neriFulvio renoldi braccoNuclear medicineBracco imaging global communicationsCorporate communicationsItalian stock exchangePhilogen groupConsilium strategic communicationsBracco groupBracco imagingItalian stockComputed tomography

vimarsana © 2020. All Rights Reserved.